BSE · APL
ASSTON PHARMACEUTICALS LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,040
of 5,004 stocks
▼ 421W
Peak #2,998 · 21 Sep 2026
ASSTON PHARMACEUTICALS LIMITED, a microcap Healthcare business, is growing revenue modestly, trades at a moderate earnings multiple, and posts a modest return on equity.
Market Cap
83.00 Cr
P/E Ratio
21.47
P/B Ratio
2.14
ROE
9.95%
ROCE
12.25%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q4 2025-26 | Q4 2024-25 |
|---|---|---|
| Revenue | 10.05 Cr | 9.07 Cr |
| Net Profit | 48.30 L | 1.95 Cr |
| EPS | 1.14 | 2.29 |
| Operating Profit | -3.05 Cr | 3.15 Cr |
Shareholding pattern
Promoter
50.66%
Public
49.34%
PUBLIC BREAKDOWN
FII
1.91%
Individuals
42.01%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.